News and Events

News and Events

News

  • Topcon Healthcare Announces Opening of THINC EMEA in London’s Knowledge Quarter

    London, United Kingdom — 26 February 2026: Topcon Healthcare proudly announces the opening of the Topcon Healthcare Innovation Center (THINC) in the heart of London’s Knowledge Quarter.THINC will function as an advanced innovation center, specifically designed to foster collaboration among eye and healthcare professionals, academic institutions, industry and patient associations and technology partners across Europe, the Middle East, and Africa (EMEA). The center will focus on accelerating the development and adoption of oculomics by providing state-of-the-art facilities for clinical research, data analysis, and technology validation. It will offer educational programs, workshops, and hands-on demonstrations of emerging diagnostic imaging technologies, supporting knowledge exchange and professional growth.By facilitating cross-disciplinary partnerships and supporting both start-ups and established organizations, THINC EMEA aims to drive the integration of ocular biomarkers into mainstream healthcare, ultimately reducing costs, increasing efficiency and improving patient outcomes, addressing the most pressing needs within the EMEA region.Building on the successful establishment and resulting accelerated development of THINC in La Jolla, California, THINC EMEA embodies Topcon Healthcare’s commitment to fostering global collaboration and pioneering new technologies that place the eye at the center of healthcare. The center will catalyze partnerships among clinicians, researchers, technology leaders, industry groups, and government agencies, advancing best practices and innovative approaches that leverage the eye as a window to the body for broader systemic health impacts beyond visual health.The centre is proud to incubate Cascader, its first start-up, born out of a collaboration between Moorfields Eye Hospital, University College London (UCL), and Topcon Healthcare. Cascader aims to redefine oculomics—the emerging field that uses eye data to inform systemic health—by developing novel analytics to unlock new insights for eye care professionals.THINC EMEA is honoured to extend the efforts of Alliance of Healthcare from the Eye, into Europe, Middle East and Africa by establishing a regional working group. The Alliance of Healthcare from the Eye is a consortium of healthcare organizations consisting of health systems, physicians, payers, researchers, policy makers, regulators, data privacy experts and representatives from industry and government, working to expand access to affordable healthcare and improve clinical outcomes by enabling the ethical and impactful adoption of oculomics in real-world practice. Ali Tafreshi, CEO of Topcon Healthcare, commented: “The opening of THINC EMEA marks a major milestone in our global strategy to empower healthcare professionals with the resources and collaborative networks needed for breakthrough innovation. London’s Knowledge Quarter provides the ideal ecosystem for accelerating progress in establishing oculomics at the centre of healthcare, and we are thrilled to extend our reach and impact through this new initiative.”Shigehiro Ogino, Managing Director of Topcon Europe Medical, added: “We are committed to serving the EMEA region with excellence and vision. THINC EMEA will be instrumental in nurturing talent, supporting start-ups, and translating cutting-edge research into real-world solutions for patients throughout the region.”Krysten Williams, Head of THINC EMEA, said: “Our innovation centre is designed to incubate and accelerate the development of oculomics, bringing together innovators, clinicians, industry and government officials to tackle the most pressing challenges to making Healthcare from the Eye a reality across the region.”THINC EMEA is pleased to announce its participation at the 100% Optical exhibition, on stand J60. Attendees will have the opportunity to experience the latest innovations from Topcon Healthcare and learn more about its portfolio companies, and our connected care platform designed to support data access and patient pathways that will make the delivery of oculomics possible in the future.For media enquiries, partnership opportunities, or to learn more about THINC EMEA and upcoming events:Visit: https://topconhealthcare.com/thinc/Email: thinc.emea@topcon.com About Topcon Healthcare Inc.Topcon Healthcare, Inc. is part of Topcon Corporation, a leading provider of digital healthcare solutions. Our vision is to improve access and quality of healthcare while reducing the cost of care. To achieve this vision, we created Healthcare from the Eye™, a connected care ecosystem that leverages AI-powered disease detection and management applied to noninvasive retinal imaging. For more information, visit topconhealthcare.com.Media Contacts:Topcon HealthcareMely MedelHead of Marketing EMEAmedia@topconhealthcare.com

  • Topcon Healthcare Acquires Intelligent Retinal Imaging Systems to Enhance Connected Care Across Primary and Eye Care

    LA JOLLA, CA & PENSACOLA, FL – Topcon Healthcare, Inc., a global leader in digital health and ocular data solutions, today announced the acquisition of Intelligent Retinal Imaging Systems (IRIS), the U.S.-based pioneer in cloud-based retinal screening technology. This strategic acquisition marks a major step in enhancing Topcon Healthcare’s presence in primary care, reinforcing its commitment to early disease detection through connected, data-driven care.IRIS is recognized for its ability to bring retinal screenings into routine clinical settings, empowering primary care physicians, Federally Qualified Health Centers, and health systems to identify undiagnosed retinal disease as part of standard preventive care. Its platform features seamless EMR integration, AI-assisted diagnostics, and broad camera compatibility, enabling providers to screen for diabetic retinopathy and other conditions efficiently and at scale.By integrating IRIS into its Healthcare from the Eye™ initiative, Topcon Healthcare is further strengthening bidirectional care coordination between primary care providers (PCPs) and eye care providers (ECPs). This acquisition supports the vision of a connected care model in which patients at risk for eye diseases can be identified earlier in primary care and referred to ECPs for timely diagnosis and treatment. In turn, ECPs using AI-analyzed ocular data to detect signs of systemic or neurological disease will be better equipped to refer patients back to primary care for further evaluation, creating a feedback loop that enhances outcomes and closes care gaps.“This acquisition reflects our long-term strategy to connect the continuum of care through intelligent platforms that bring together data, workflow, and real-time decision support,” said Jacques Gilbert, Chief Strategy & Business Development Officer at Topcon Healthcare, Inc.The IRIS platform will also enhance Harmony®, Topcon Healthcare’s cloud-based connected care platform. Harmony is designed to unify imaging, clinical insights, and AI analytics across care settings. With the integration of IRIS’s referral and communication capabilities, Harmony will provide a more robust infrastructure to support shared clinical decision-making, improve compliance, and reduce patient leakage across the healthcare continuum.“IRIS enables us to expand the reach of the Healthcare from the Eye™ initiative into primary care, strengthening coordination between PCPs and ECPs, and ensuring patients receive timely, targeted care,” Gilbert added.Steven Martin, CEO at IRIS, commented on the opportunity to scale impact with Topcon Healthcare’s support: “With Topcon Healthcare’s investment in connected care infrastructure, we’re well-positioned to expand our impact. Together, we’ll ensure providers of all sizes can confidently deliver preventive screenings that improve outcomes and reduce disparities.”Since its founding in 2012, IRIS has enabled more than 1.8 million screenings, identified over 279,000 cases of diabetic retinopathy, and supported more than 650 healthcare organizations in improving quality scores and addressing care gaps. The IRIS team will continue operating from its headquarters in Pensacola, Florida, as an affiliate of Topcon Healthcare.With diagnostic modules in development for cardiovascular disease, chronic kidney disease, and early Alzheimer’s detection, the integration of IRIS into Topcon Healthcare’s expanding platform will further elevate the clinical value of ocular data and bring the Healthcare from the Eye™ vision to more providers and patients across the continuum of care.About IRISIRIS is the U.S. leader in AI-assisted diabetic retinopathy screening at the point of care. Through its camera-agnostic, cloud-based platform, IRIS empowers healthcare providers to eliminate preventable blindness through early detection and accessible technology. Learn more at www.retinalscreenings.com. Bailey & Company acted as the exclusive financial advisor to IRIS in connection with the transaction.About Topcon Healthcare, Inc.Topcon Healthcare, Inc. is part of Topcon Corporation, a leading provider of digital healthcare solutions. Our vision is to improve access and quality of healthcare while decreasing the cost of care. To achieve this vision, we created Healthcare from the Eye™, a connected care ecosystem using AI-powered disease detection and management applied to noninvasive retinal imaging.For more information, please visit topconhealthcare.com

  • Pangaea Data Secures Strategic Investment from Topcon Healthcare, Inc. to Close Global Care Gaps in Eye Health

    SOUTH SAN FRANCISCO, CA; LONDON, UK; and LA JOLLA, CA – Pangaea Data, a health AI company specializing in identifying untreated and under-treated patients at scale, today announced a strategic investment from Topcon Healthcare, Inc., a global leader in ophthalmic medical devices and digital health solutions. The collaboration aims to accelerate the application of Pangaea’s clinically validated AI platform to address critical care gaps in eye health and systemic disease.Pangaea Data’s platform automatically analyzes structured and unstructured patient records against clinical guidelines, emulating a clinician’s manual review, to uncover patients who meet diagnostic or treatment criteria, but are not currently in a treatment or management process. Integrated directly into existing EHR and downstream scheduling systems, the platform enables real-time clinical action without disrupting workflows.“We are thrilled to partner with Topcon Healthcare to scale our platform’s reach and improve timely diagnosis and treatment across eye care,” said Dr. Vibhor Gupta, Founder and CEO of Pangaea Data. “Together, we can empower providers to close care gaps while generating actionable insights for population health, discovery science, and value-based care.”Through this partnership, Pangaea Data’s AI platform will leverage Topcon Healthcare’s Harmony® digital health platform, creating a seamless interface for optometry and ophthalmology practices to identify patients needing follow-up or further evaluation. This includes patients with conditions such as glaucoma, 50% of whom remain undiagnosed in the U.S.1, and diabetic retinopathy, where more than one-third of diagnosed diabetics do not receive their recommended annual eye screening2.“Pangaea Data’s unique ability to find missed patients using AI, and to do so without burdening clinicians, has powerful implications for eye care and beyond,” said Ali Tafreshi, CEO & President of Topcon Healthcare, Inc. “This partnership supports our Healthcare from the Eye™ initiative, which uses ocular data and AI to transform how systemic and ocular diseases are detected and managed. We are proud to support Pangaea Data’s mission through this strategic investment.”Pangaea Data’s platform has already demonstrated impact across multiple therapeutic areas, including pulmonology, cardiology, oncology, nephrology, and infectious diseases. The company’s expansion into eye care through this partnership represents a significant step in advancing AI-driven clinical care globally.1 Current Glaucoma Programs | Vision and Eye Health | CDC – https://www.cdc.gov/vision-health/php/glaucoma-programs/index.html2 Diabetic Retinopathy Screening – EyeWiki – https://eyewiki.org/Diabetic_Retinopathy_ScreeningAbout Pangaea DataPangaea Data provides an AI platform that is configured on clinical guidelines to mimic and therefore automate a clinician’s manual process for finding untreated (undiagnosed, misdiagnosed, miscoded, at-risk, uncontrolled) and under-treated patients with hard-to-diagnose conditions for screening and treatment at the point of care. These patients may otherwise be missed, despite information available in their health records, due to treatment for other conditions or administrative reasons. Pangaea’s platform is designed to be deployed behind the healthcare provider’s firewall, without moving data, facilitating privacy compliance. Furthermore, the platform is designed to seamlessly integrate with existing EHR systems, avoiding disruption to existing clinical or IT workflows. Pangaea Data’s founders, Dr. Vibhor Gupta and Prof. Yike Guo, have over 20 years of academic and industry experience. Their advisors and investors include industry veterans, such as Lord David Prior (Former Chairman, NHS England) and Mr. Andy Palmer (Former Head of Systems Integration, Novartis). For more information, visit www.pangaeadata.aiAbout Topcon Healthcare, Inc.Topcon Healthcare, Inc. is part of Topcon Corporation, a leading provider of digital healthcare solutions. Our vision is to improve access and quality of healthcare while decreasing the cost of care. To achieve this vision, we created Healthcare from the Eye™, a connected care ecosystem using AI-powered disease detection and management applied to noninvasive retinal imaging.

SEE MORE

Topics

  • Discontinuation of Social Courtesy Gifts and Small Promotional Items in Compliance with APEC Kuala Lumpur Principles

    The Asia-Pacific Economic Cooperation (APEC), in which the Japan Federation of Medical Devices Associations (JFMDA) participates, has established the Kuala Lumpur Principles (KL Principles)—ethical guidelines for interactions between the medical device industry, healthcare professionals, and patients.In alignment with these principles, JFMDA revised the Medical Device Industry Promotion Code on April 11, 2024, with implementation effective January 1, 2026.Accordingly, we will discontinue the provision of social courtesy gifts and small promotional items to healthcare professionals and institutions to further enhance transparency in our relationships.Examples of items to be discontinued:Social courtesy gifts (e.g., souvenirs, seasonal gifts, congratulatory flowers, condolence offerings)Promotional items (e.g., novelty goods such as pens and notebooks, event souvenirs, calendars)We appreciate your understanding and cooperation as we continue to uphold the highest standards of ethics and transparency in our industry.

  • Topcon Introduces TRK-3 OMNIA Auto Kerato-Refracto Tonometer to the Asian Market

    Topcon Healthcare, a leading provider of medical devices andsoftware solutions for the global eye care community, is pleased toannounce the launch the TRK-3 OMNIA to the Asian Market.The TRK-3 OMNIA is a new auto kerato-refracto tonometer that will help eye care professionals optimise their clinical workflow and streamline patient care.The new TRK-3OMNIA is a 4-in-1 instrument that offers a combined refractometer, keratometer, non-contact tonometer, and pachymeter in one compact instrument. Capturing four measurements with a single device will help eye care professionals drive efficiency while improving patient comfort by eliminating the need to move between multiple devices. The TRK-3 OMNIA offers significant enhancements that build upon the strong performance of its predecessor. The quick, one-touch operation is complemented by the patented rotary prism technology that delivers stable measurements while the improved user interface elevates ease of use. The addition of DICOM enhances TRK-3 OMNIA connectivity. About Topcon Topcon’s vision is to provide healthcare professionals with intelligent, efficient technologies to improve patient care. In the fast-changing healthcare market, we offer the latest integrated solutions, including multimodal imaging, vendor-inclusive data management, and revolutionary remote diagnostic technology. Topcon Corporation strives to develop solutions tailored to the societal challenges of healthcare, agriculture, and infrastructure. In the healthcare sector, the biggest challenges are prevalence of eye diseases, access to healthcare, and the shortage of doctors. By investing in cutting-edge technologies, Topcon Corporation works to improve people’s health and quality of life. https://topconhealthcare.jp/products/trk-3-omnia/Note: The information contained on this website is intended for healthcare professionals. Not all products, services, or offers are approved or offered in every market, and products vary from one country to another. Contact your local distributor for country-specific information and availability.

  • Public statement regarding recent lawsuit settlement

    Topcon Healthcare is pleased to announce we have reached a positive resolution to a lawsuit with Carl Zeiss Meditec that has been a distraction for over four years. Topcon made a strategic decision to settle ongoing litigation with Zeiss to remove the distraction and allow us to focus on our mission to serve our customers and help improve access and quality of care while reducing the overall cost of care. We are known for quality products and quality people.  We intend to continue delivering value and intelligent solutions to our customers and the healthcare market.  Topcon admitted no wrongdoing in the settlement.  During the (4 years of) litigation almost all of Zeiss’s claims were dismissed or withdrawn.  The final settlement relates to a legacy version of Harmony (which has not been actively licensed by Topcon for several years).  Customers using our current product, Harmony RS, are not affected by the settlement, and none of the devices or software that we are promoting or plan to implement in the future are affected by the conditions in the settlement in any way. 

SEE MORE

Events

  • TODAY
  • EVENT

Upcoming Events